Evaluation of Adherence With Bisphosphonates and Calcium and Vitamin D Supplements in Women With Postmenopausal Osteoporosis
NCT ID: NCT07105163
Last Updated: 2025-08-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
480 participants
OBSERVATIONAL
2025-03-03
2025-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study and Follow-up of the Clinical Effectiveness and Comparative Safety of Biosimilar Teriparatide in the Management of Postmenopausal or Senile.
NCT05369013
Bisphosphonates for Prevention of Post-Denosumab Bone Loss
NCT03396315
Resolution of Effect of Bisphosphonates on Bone in Postmenopausal Osteoporosis
NCT01406613
Denosumab Adherence Preference Satisfaction Study
NCT00518531
A Study To Investigate The Metabolism And Excretion Of 14C SB-751689 Given To Healthy Males And Postmenopausal Women
NCT00499928
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
CROSS_SECTIONAL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. \- Women who had been prescribed oral treatment with a BP administered monthly or weekly together with a Ca/D supplement (sachets or chewable tablets) administered daily, at least 6 months prior to inclusion in the study.
3. \- Women who had given their written informed consent before participating in the study.
Exclusion Criteria
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Procare Health Iberia S.L.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Clinica Gaias Santiago
Santiago de Compostela, A coruña, Spain
CP Dr Caracuel
Córdoba, Andalusia, Spain
Hospital Reina Sofia
Córdoba, Andalusia, Spain
Hospital Virgen del Rocio
Seville, Andalusia, Spain
CP Dr Agramonte
Palma de Mallorca, Balearic Islands, Spain
CP Dr Balta
Palma de Mallorca, Balearic Islands, Spain
CHU Insular - H Materno-Infantil
Las Palmas de Gran Canaria, Canary Islands, Spain
CHU Insular - H Materno-Infantil
Las Palmas de Gran Canaria, Canary Islands, Spain
Hospital Zamora
Zamora, Castille and León, Spain
Clinica Sagrada Familia
Barcelona, Catalonia, Spain
CP Dra Sanchez
Barcelona, Catalonia, Spain
Hospital del Mar
Barcelona, Catalonia, Spain
Hospital del Tajo
Aranjuez, Madrid, Spain
CP Dr Solano
Madrid, Madrid, Spain
CP Dr Zafra
Madrid, Madrid, Spain
CP Dra Gerechter
Madrid, Madrid, Spain
Hospital Infanta Leonor
Madrid, Madrid, Spain
Hospital Virgen del Mar
Madrid, Madrid, Spain
CP Dr Larrauri
Vigo, Pontevedra, Spain
CP Dra Medrano
Alicante, Valencia, Spain
CP Dra Tejon
Alicante, Valencia, Spain
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
OSTEOAD
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.